Current Molecular Medicine
Title:Meet Our Associate Editor:
Volume: 15 Issue: 6
Author(s): Claudio A. Hetz
Affiliation:
Export Options
About this article
Cite this article as:
Hetz A. Claudio, Meet Our Associate Editor:, Current Molecular Medicine 2015; 15 (6) . https://dx.doi.org/10.2174/156652401506150819100222
DOI https://dx.doi.org/10.2174/156652401506150819100222 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
20
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in Current Diabetes Proteomics: From the Perspectives of Label- free Quantification and Biomarker Selection
Current Drug Targets Aquaporins and Neurodegenerative Diseases
Current Neuropharmacology Lipoic Acid, a Lead Structure for Multi-Target-Directed Drugs for Neurodegeneration
Mini-Reviews in Medicinal Chemistry Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors
Anti-Cancer Agents in Medicinal Chemistry Role of Antioxidants in Redox Regulation of Diabetic Cardiovascular Complications
Current Pharmaceutical Biotechnology HSP27: Mechanisms of Cellular Protection Against Neuronal Injury
Current Molecular Medicine Cell-Replacement Therapy with Stem Cells in Neurodegenerative Diseases
Current Neurovascular Research Modelling Human Disease with Pluripotent Stem Cells
Current Gene Therapy Mitochondrial Generation of Reactive Oxygen Species and its Role in Aerobic Life
Current Medicinal Chemistry The Potential Roles of Metallothionein as a Therapeutic Target for Cerebral Ischemia and Retinal Diseases
Current Pharmaceutical Biotechnology Nanoneuromedicines for Neurodegenerative Diseases
Nanoscience & Nanotechnology-Asia P2X7 Receptors: Channels, Pores and More
CNS & Neurological Disorders - Drug Targets Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease
Current Medicinal Chemistry Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells
Current Medicinal Chemistry AAV as a Gene Transfer Vector for the Treatment of Neurological Disorders: Novel Treatment Thoughts for ALS
Current Gene Therapy Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism
Current Drug Metabolism Mesenchymal Stem Cells: Potential in Treatment of Neurodegenerative Diseases
Current Stem Cell Research & Therapy Targeting Hsp90 in Non-Cancerous Maladies
Current Topics in Medicinal Chemistry Molecular and Cellular Control of Dendrite Maturation During Brain Development
Current Molecular Pharmacology Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application
Current Molecular Pharmacology